IG 257 Pill — WHITE OVAL, 9mm — Nabumetone

No photo available

Imprint	IG / 257
Colour	WHITE
Shape	OVAL
Size	9
Strength	NABUMETONE 500 mg
Dosage form	Tablet, Film Coated
Manufacturer	Blenheim Pharmacal, Inc.
NDC	10544-003
Schedule	—
Availability	—
Ingredients	NABUMETONE[NABUMETONE]

What does this imprint mean?

The imprint "IG 257" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Nabumetone

Uses and warnings

BOXED WARNING: Cardiovascular and gastrointestinal risk. NSAIDs including nabumetone "cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal," and nabumetone is "contraindicated in the setting of coronary artery bypass graft (CABG) surgery." NSAIDs also "cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal." Also contraindicated in patients with known hypersensitivity to nabumetone or its excipients, and in those with prior asthma, urticaria, or allergic-type reactions to aspirin or other NSAIDs; use is cautioned against post-MI and in severe heart failure.

Nabumetone tablets, USP are indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis." Use is recommended at "the lowest effective dose for the shortest duration consistent with individual patient treatment goals.

Read the full drug profile →